- 亨迪藥業
- 12.480-0.070 (-0.558%)
盈利能力分析
- 0.916
- 3.924
- 7.602
- 5.592
- 8.323
- 0.856
- 3.636
- 6.981
- 5.210
- 7.764
- 0.906
- 3.871
- 7.409
- 5.477
- 8.244
邊際利潤分析
- 20.535
- 28.841
- 40.172
- 28.878
- 33.943
- 7.433
- 22.626
- 30.969
- 28.884
- 25.764
- 4.694
- 11.378
- 22.955
- 15.967
- 26.040
- 6.564
- 20.533
- 26.562
- 24.430
- 22.502
收益指標分析
- 1.226
- 78.540
- 96.296
- 94.033
- 84.775
- 94.658
- 18.950
- 1.982
- 0.000
- 7.691
- -2.543
- -0.461
- -1.242
- -0.871
- -0.073
償債能力分析
- 13.952
- 11.404
- 11.984
- 10.660
- 20.670
- 12.996
- 10.565
- 10.992
- 10.111
- 19.802
- 5.921
- 7.191
- 7.457
- 8.895
- 4.614
- 0.523
- 0.489
- 0.932
- 2.985
- 0.271
- 18,887.427
- 20,215.891
- 10,560.344
- 3,230.841
- 36,672.936
- 1,588.977
- 1,290.566
- 1,241.104
- 1,024.271
- 2,067.151
- -1.837
- -1.021
- -3.007
- -1.260
- 88.477
營運能力分析
- 38.513
- 40.804
- 33.696
- 70.748
- 72.624
- 138.441
- 176.813
- 130.916
- 100.365
- 112.946
回顧25 展望26
大國博弈
More